YHB Investment Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History

YHB Investment Advisors’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$418K	Hold	841	–	–	0.03%	233
2026 Q1	$376K	Hold	841	–	–	0.03%	231
2025 Q4	$381K	Sell	841 -52	-6%	-$22.4K	0.03%	230
2025 Q3	$350K	Buy	893 +2	+0.2%	+$836	0.03%	239
2025 Q2	$397K	Sell	891 -50	-5%	-$23K	0.03%	226
2025 Q1	$456K	Buy	941 +100	+12%	+$46.6K	0.04%	211
2024 Q4	$339K	Buy	+841	New	+$390K	0.03%	222

Other funds holding VRTX

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

BHIA

Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return

CTB

Country Trust Bank Bloomington, Illinois $5.71B AUM 25.48% 1-Year Est. Return

AAIS

ABN AMRO Investment Solutions Paris Cedex 008 $11.5B AUM 32.2% 1-Year Est. Return

YHB Investment Advisors's VRTX Position: Q2 2026 in Review

YHB Investment Advisors held its Vertex Pharmaceuticals (VRTX) position steady in Q2 2026 at 841 shares worth $418K. The position accounts for 0.03% of the portfolio, ranked #233.

YHB Investment Advisors first reported a position in VRTX in Q4 2024 and has held it in 7 quarters since. The position peaked at $456K in Q1 2025. 429 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

YHB Investment Advisors held 841 shares of Vertex Pharmaceuticals worth $418K as of Q2 2026.
YHB Investment Advisors left its Vertex Pharmaceuticals share count unchanged in Q2 2026.
Vertex Pharmaceuticals made up 0.03% of YHB Investment Advisors's portfolio in Q2 2026, its #233 holding.
YHB Investment Advisors first reported a position in Vertex Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
YHB Investment Advisors's Vertex Pharmaceuticals position peaked at $456K in Q1 2025.
429 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on YHB Investment Advisors's 13F filing for Q2 2026, filed 14 Jul 2026.